Abstract:<p>Profiling impurities for the active pharmaceutical ingredients (APIs) is an indispensable step in drug development process. Nowadays, high resolution mass spectrometry is the first choice for determining the chemical formula of organic impurities. However, merely base on the accurate mass to screen the formula is obviously not a flawless method. In this paper, a reliable strategy based on Fourier transform ion cyclotron resonance mass spectrometry <strong>(</strong>FT-ICR MS) was presented to profile the related impurities. Firstly, Cefteram pivoxil was subjected to forced degration under hydrolytic (acidic and basic), oxidative, photolytic and thermal conditions according to ICH guidelines. Then, a highly specific and efficient HPLC-FT-ICR MS compatible method was developed and it was used to separate and characterize the process related substances and the major degradation products in Cefteram pivoxil. Next, isotopic fine structures (IFSs) of all impurities were acquired to decisively determine their elemental composition. Finally, the possible chemical structures of impurities were predicted by combining the information of accurate mass, retention time, IFSs and characteristic fragmentation ions. As a result, a total of 20 related substances including 6 process related substances and 14 degradation products were identified and characterized. To the best of our knowledge, 13 of these related substances were not reported in the previous literature. It indicates that the developed strategy is accurate and standard independent to determine the chemical formulae of organic impurities in APIs. In conclusion, the impurity profiles obtained in this study are critical to the quality control and stability study of Cefteram pivoxil. Moreover, the developed method can be used as a versatile workflow to profile the impurities in APIs in the future, especially for the unknown impurities.</p>

Identification of undescribed key impurities of homoharringtonine bulk drug

Characterisation and Critical Processes Identification for Production of Herbal Preparations Using 1H-NMR and Chemometrics: A Case Study of Trichosanthis Pericarpium Injection.

HPLC-fluorescence detection for stability of harringtonine, and identification of degradation products by UPLC-Q-TOF-MS

Chemical Fingerprint for Identification and Quality Control of Saccharides in Danhong Injection Based on HPLC-ELSD with Chemometrics

Characterization of the Trace-Level Impurities in the Bulk Drug Citalopram by High-Performance Liquid Chromatography/Tandem Multistage Mass Spectrometry

Identification of an Unknown Trace-Level Impurity in Bulk Drug of Seroquel by High-Performance Liquid Chromatography Combined with Mass Spectrometry

Research progress on the impurities identification and determination in pharmaceuticals

Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.

Identification, Characterization, And Synthesis Of Process-Related Impurities In Antiproliferative Agent Tq-B3203

Study of Impurity Profiles in Raw Materials and Tablets of Rutin and Its Production Process: Correlation Analysis

Analysis of related substances in synthetical arbutin and its intermediates by HPLC–UV and LC–ESI–MS

A Drug–Excipient Interaction Impurity of Bromhexine Hydrochloride Injection: Structure and Formation Mechanism Elucidation

Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry

Identification and Quality Control Strategy of Impurities in Zhengqing Fengtongning Injection

Impurity profiling of Cefteram pivoxil based on Fourier transform ion cyclotron resonance MS

Characterization of Impurities in the Bulk Drug Lisinopril by Liquid Chromatography/ion Trap Spectrometry

Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.

Isolation and identification of four major impurities in capreomycin sulfate.

Assessment of the Purity of IMM-H014 and Its Related Substances for the Treatment of Metabolic-Associated Fatty Liver Disease Using Quantitative Nuclear Magnetic Resonance Spectroscopy

Mass-spectrometry-directed Analysis and Purification of Pyrrolizidine Alkaloidcis/transisomers Ingynura Japonica

Structurally related impurity profiling of thiacloprid by orbitrap and de novo identification tool